Novartis committed to CAR-Ts – but doubts about commercial viability remain
Novartis may have concerns about commercial prospects, says expert.
X
Novartis committed to CAR-Ts – but doubts about commercial viability remain
https://pharmaphorum.com/views-and-analysis/will-car-t-profitable-pharma/